Fortress Biotech, Inc.

FBIONASDAQUSD
2.87 USD
0.10 (3.61%)AT CLOSE (11:59 AM EDT)
2.89
0.02 (0.52%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
2.89
0.02 (0.52%)
🔴Market: CLOSED

Fortress Biotech, Inc. (FBIO) trades at $2.87 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (63.0%) and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest FBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Aug 21, 2026.

Open?$2.80
High?$2.88
Low?$2.79
Prev. Close?$2.77
Volume?202.7K
Avg. Volume?700.3K
VWAP?$2.84
Rel. Volume?0.29x
Bid / Ask
Bid?$2.82 × 2.0K
Ask?$2.93 × 700
Spread?$0.11
Midpoint?$2.88
Valuation & Ratios
Market Cap?95.7M
Shares Out?33.4M
Float?24.5M
Float %?78.9%
P/E Ratio?0.93
P/B Ratio?0.58
EPS?$3.10
Dividend?0.35%
Ex-Dividend?N/A
News
Profile
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Employees
78
Market Cap
95.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2011-11-17
Address
1111 KANE CONCOURSE
BAY HARBOR ISLANDS, FL 33154
Phone: 781-652-4500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
0
Momentum?
33
Short Sent.?
34
Piotroski F-Score?5/9Mixed
Altman Z-Score?-1.62Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.62%Squeeze Risk
Short Interest?5.8M
Days to Cover?12.0
Free Float24.5M
Avg Daily Volume481.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?3.96Strong
Quick Ratio?3.83Strong
Cash Ratio?3.17Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.9CHEAP
P/B?
Peers
100
S&P
97
0.58CHEAP
P/S?
Peers
100
S&P
81
1.37CHEAP
P/FCF?
Peers
100
S&P
97
0.8CHEAP
EV/EBITDA?
Peers
100
S&P
97
2.6CHEAP
EV/Sales?
S&P
97
-0.88CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
93
63.0%STRONG
ROA?
Peers
50
S&P
97
32.6%STRONG
Cash Flow & Enterprise
FCF?$125.8M
Enterprise Value?$-61256650
Fundamentals ratios updated end of day